1. Home
  2. DLO vs ADMA Comparison

DLO vs ADMA Comparison

Compare DLO & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLO
  • ADMA
  • Stock Information
  • Founded
  • DLO 2013
  • ADMA 2004
  • Country
  • DLO Uruguay
  • ADMA United States
  • Employees
  • DLO N/A
  • ADMA N/A
  • Industry
  • DLO Business Services
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DLO Consumer Discretionary
  • ADMA Health Care
  • Exchange
  • DLO Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • DLO 4.0B
  • ADMA 3.5B
  • IPO Year
  • DLO 2021
  • ADMA N/A
  • Fundamental
  • Price
  • DLO $15.51
  • ADMA $15.57
  • Analyst Decision
  • DLO Buy
  • ADMA Strong Buy
  • Analyst Count
  • DLO 9
  • ADMA 3
  • Target Price
  • DLO $15.00
  • ADMA $27.67
  • AVG Volume (30 Days)
  • DLO 2.4M
  • ADMA 3.4M
  • Earning Date
  • DLO 11-12-2025
  • ADMA 11-07-2025
  • Dividend Yield
  • DLO 3.29%
  • ADMA N/A
  • EPS Growth
  • DLO 9.30
  • ADMA 469.09
  • EPS
  • DLO 0.48
  • ADMA 0.85
  • Revenue
  • DLO $863,482,000.00
  • ADMA $474,174,000.00
  • Revenue This Year
  • DLO $38.48
  • ADMA $21.08
  • Revenue Next Year
  • DLO $27.49
  • ADMA $25.98
  • P/E Ratio
  • DLO $32.33
  • ADMA $18.42
  • Revenue Growth
  • DLO 22.02
  • ADMA 43.58
  • 52 Week Low
  • DLO $7.61
  • ADMA $13.50
  • 52 Week High
  • DLO $16.78
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • DLO 58.83
  • ADMA 54.74
  • Support Level
  • DLO $14.46
  • ADMA $14.58
  • Resistance Level
  • DLO $15.88
  • ADMA $16.08
  • Average True Range (ATR)
  • DLO 0.86
  • ADMA 0.58
  • MACD
  • DLO 0.01
  • ADMA 0.20
  • Stochastic Oscillator
  • DLO 61.04
  • ADMA 71.75

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: